Organic Salts of Pharmaceutical Impurity p-Aminophenol

The presence of impurities can drastically affect the efficacy and safety of pharmaceutical entities. p-Aminophenol (PAP) is one of the main impurities of paracetamol (PA) that can potentially show toxic effects such as maternal toxicity and nephrotoxicity. The removal of PAP from PA is challenging and difficult to achieve through regular crystallization approaches. In this regard, we report four new salts of PAP with salicylic acid (SA), oxalic acid (OX), l-tartaric acid (TA), and (1S)-(+)-10-camphorsulfonic acid (CSA). All the PAP salts were analyzed using single-crystal X-ray diffraction, powder X-ray diffraction, infrared spectroscopy, differential scanning calorimetry, and thermogravimetric analysis. The presence of minute amounts of PAP in paracetamol solids gives a dark color to the product that was difficult to remove through crystallization. In our study, we found that the addition of small quantities of the aforementioned acids helps to remove PAP from PA during the filtration and washings. This shows that salt formation could be used to efficiently remove challenging impurities.

[1]  P. Frawley,et al.  Plastically bendable pregabalin multi-component systems with improved tabletability and compressibility , 2020 .

[2]  A. Maguire,et al.  Cocrystals and a Salt of the Bioactive Flavonoid: Naringenin , 2018, Crystal Growth & Design.

[3]  A. Maguire,et al.  Symmetry assisted tuning of bending and brittle multi-component forms of probenecid. , 2017, Chemical communications.

[4]  A. Nangia,et al.  Polymorphism, isostructurality and physicochemical properties of glibenclamide salts , 2017 .

[5]  R. Tan,et al.  Novel solid forms of oxaprozin: cocrystals and an extended release drug–drug salt of salbutamol , 2016 .

[6]  H. N. Shalini,et al.  Biological removal of phenol from wastewaters: a mini review , 2015, Applied Water Science.

[7]  A. Nangia,et al.  High solubility crystalline hydrates of Na and K furosemide salts , 2014 .

[8]  A. Nangia,et al.  Lornoxicam Salts: Crystal Structures, Conformations, and Solubility , 2014 .

[9]  Pui Shan Chow,et al.  Pharmaceutical Salts of Haloperidol with Some Carboxylic Acids and Artificial Sweeteners: Hydrate Formation, Polymorphism, and Physicochemical Properties , 2014 .

[10]  A. Healy,et al.  Formation and physicochemical properties of crystalline and amorphous salts with different stoichiometries formed between ciprofloxacin and succinic acid. , 2013, Molecular pharmaceutics.

[11]  A. Nangia,et al.  Salts and Ionic Liquid of The Antituberculosis Drug S,S-Ethambutol , 2013 .

[12]  Marc-Antoine Perrin,et al.  Efficient Purification of an Active Pharmaceutical Ingredient via Cocrystallization: From Thermodynamics to Scale-Up , 2013 .

[13]  D. Snodin,et al.  Guidelines and pharmacopoeial standards for pharmaceutical impurities: overview and critical assessment. , 2012, Regulatory toxicology and pharmacology : RTP.

[14]  A. Myerson,et al.  Separation of impurities from solution by selective co-crystal formation , 2012 .

[15]  Frances Liu,et al.  Identification of pharmaceutical impurities in formulated dosage forms. , 2011, Journal of pharmaceutical sciences.

[16]  Jiben Roy,et al.  Pharmaceutical impurities—A mini-review , 2002, AAPS PharmSciTech.

[17]  Abu T M Serajuddin,et al.  Salt formation to improve drug solubility. , 2007, Advanced drug delivery reviews.

[18]  Shuang Song,et al.  p-Aminophenol degradation by ozonation combined with sonolysis: operating conditions influence and mechanism. , 2007, Ultrasonics sonochemistry.

[19]  T. McGovern,et al.  Toxicological overview of impurities in pharmaceutical products. , 2007, Advanced drug delivery reviews.

[20]  S. Min,et al.  Degradation of 4-aminophenol by hydrogen peroxide oxidation using enzyme from Serratia marcescens as catalyst , 2007 .

[21]  A. Nangia,et al.  Tape and layer structures in cocrystals of some di- and tricarboxylic acids with 4,4′-bipyridines and isonicotinamide. From binary to ternary cocrystals , 2005 .

[22]  Y. Li,et al.  Comparison of para-aminophenol cytotoxicity in rat renal epithelial cells and hepatocytes. , 2005, Toxicology.

[23]  E. Bomhard,et al.  Genotoxic Activities of Aniline and its Metabolites and Their Relationship to the Carcinogenicity of Aniline in the Spleen of Rats , 2005, Critical reviews in toxicology.

[24]  M. Ray,et al.  p‐Aminophenol‐induced hepatotoxicity in hamsters: Role of glutathione , 2004, Journal of biochemical and molecular toxicology.

[25]  Z. Fijałek,et al.  Determination of 4-aminophenol impurities in multicomponent analgesic preparations by HPLC with amperometric detection. , 2003, Journal of pharmaceutical and biomedical analysis.

[26]  B. Keskinler,et al.  Removal of phenol from water by membrane-immobilized enzymes: Part I. Dead-end filtration , 2002 .

[27]  H. Song,et al.  p‐Aminophenol‐induced liver toxicity: Tentative evidence of a role for acetaminophen , 2001, Journal of biochemical and molecular toxicology.

[28]  W. Dressler,et al.  The toxicity of p-aminophenol in the Sprague-Dawley rat: effects on growth, reproduction and foetal development. , 1989, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[29]  G. Mudge,et al.  Nephrotoxicity of p-aminophenol, a metabolite of acetaminophen, in the fischer 344 rat. , 1982, Toxicology and applied pharmacology.